TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...
Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...
Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...
Biotech firm Bio-Techne missed its first-quarter revenue estimates on Wednesday, hurt by sluggish demand for its products amid soft biotech funding environment in China.
Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on ...
Eli Lilly is doubling down on its partnership with Chinese tech outfit XtalPi, striking a new antibody development pact that ...
A Cambridge biomedical research institute that launched less than two years ago with roughly $500 million in private funding ...
Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...
Novo Nordisk lowers its 2025 profit forecast as new CEO Mike Doustdar faces rising competition, leadership changes, and a ...
Nvidia joins India’s $2 billion deep tech alliance to mentor AI and chip startups, expanding its role in the nation’s ...
Bionova Scientific announced Thursday it would bring 200 new jobs to The Woodlands over the next several years, bolstering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results